purchase customization

1 Study Coverage
1.1 Vaccines Administered Orally Product Introduction
1.2 Market by Type
1.2.1 Global Vaccines Administered Orally Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Human
1.2.3 Animal
1.3 Market by Application
1.3.1 Global Vaccines Administered Orally Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vaccines Administered Orally Sales Estimates and Forecasts 2017-2028
2.2 Global Vaccines Administered Orally Revenue Estimates and Forecasts 2017-2028
2.3 Global Vaccines Administered Orally Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vaccines Administered Orally Sales by Region
2.4.1 Global Vaccines Administered Orally Sales by Region (2017-2022)
2.4.2 Global Sales Vaccines Administered Orally by Region (2023-2028)
2.5 Global Vaccines Administered Orally Revenue by Region
2.5.1 Global Vaccines Administered Orally Revenue by Region (2017-2022)
2.5.2 Global Vaccines Administered Orally Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vaccines Administered Orally Sales by Manufacturers
3.1.1 Global Top Vaccines Administered Orally Manufacturers by Sales (2017-2022)
3.1.2 Global Vaccines Administered Orally Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccines Administered Orally in 2021
3.2 Global Vaccines Administered Orally Revenue by Manufacturers
3.2.1 Global Vaccines Administered Orally Revenue by Manufacturers (2017-2022)
3.2.2 Global Vaccines Administered Orally Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vaccines Administered Orally Revenue in 2021
3.3 Global Vaccines Administered Orally Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vaccines Administered Orally Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vaccines Administered Orally Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vaccines Administered Orally Sales by Type
4.1.1 Global Vaccines Administered Orally Historical Sales by Type (2017-2022)
4.1.2 Global Vaccines Administered Orally Forecasted Sales by Type (2023-2028)
4.1.3 Global Vaccines Administered Orally Sales Market Share by Type (2017-2028)
4.2 Global Vaccines Administered Orally Revenue by Type
4.2.1 Global Vaccines Administered Orally Historical Revenue by Type (2017-2022)
4.2.2 Global Vaccines Administered Orally Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vaccines Administered Orally Revenue Market Share by Type (2017-2028)
4.3 Global Vaccines Administered Orally Price by Type
4.3.1 Global Vaccines Administered Orally Price by Type (2017-2022)
4.3.2 Global Vaccines Administered Orally Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vaccines Administered Orally Sales by Application
5.1.1 Global Vaccines Administered Orally Historical Sales by Application (2017-2022)
5.1.2 Global Vaccines Administered Orally Forecasted Sales by Application (2023-2028)
5.1.3 Global Vaccines Administered Orally Sales Market Share by Application (2017-2028)
5.2 Global Vaccines Administered Orally Revenue by Application
5.2.1 Global Vaccines Administered Orally Historical Revenue by Application (2017-2022)
5.2.2 Global Vaccines Administered Orally Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vaccines Administered Orally Revenue Market Share by Application (2017-2028)
5.3 Global Vaccines Administered Orally Price by Application
5.3.1 Global Vaccines Administered Orally Price by Application (2017-2022)
5.3.2 Global Vaccines Administered Orally Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vaccines Administered Orally Market Size by Type
6.1.1 North America Vaccines Administered Orally Sales by Type (2017-2028)
6.1.2 North America Vaccines Administered Orally Revenue by Type (2017-2028)
6.2 North America Vaccines Administered Orally Market Size by Application
6.2.1 North America Vaccines Administered Orally Sales by Application (2017-2028)
6.2.2 North America Vaccines Administered Orally Revenue by Application (2017-2028)
6.3 North America Vaccines Administered Orally Market Size by Country
6.3.1 North America Vaccines Administered Orally Sales by Country (2017-2028)
6.3.2 North America Vaccines Administered Orally Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Vaccines Administered Orally Market Size by Type
7.1.1 Europe Vaccines Administered Orally Sales by Type (2017-2028)
7.1.2 Europe Vaccines Administered Orally Revenue by Type (2017-2028)
7.2 Europe Vaccines Administered Orally Market Size by Application
7.2.1 Europe Vaccines Administered Orally Sales by Application (2017-2028)
7.2.2 Europe Vaccines Administered Orally Revenue by Application (2017-2028)
7.3 Europe Vaccines Administered Orally Market Size by Country
7.3.1 Europe Vaccines Administered Orally Sales by Country (2017-2028)
7.3.2 Europe Vaccines Administered Orally Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vaccines Administered Orally Market Size by Type
8.1.1 Asia Pacific Vaccines Administered Orally Sales by Type (2017-2028)
8.1.2 Asia Pacific Vaccines Administered Orally Revenue by Type (2017-2028)
8.2 Asia Pacific Vaccines Administered Orally Market Size by Application
8.2.1 Asia Pacific Vaccines Administered Orally Sales by Application (2017-2028)
8.2.2 Asia Pacific Vaccines Administered Orally Revenue by Application (2017-2028)
8.3 Asia Pacific Vaccines Administered Orally Market Size by Region
8.3.1 Asia Pacific Vaccines Administered Orally Sales by Region (2017-2028)
8.3.2 Asia Pacific Vaccines Administered Orally Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Vaccines Administered Orally Market Size by Type
9.1.1 Latin America Vaccines Administered Orally Sales by Type (2017-2028)
9.1.2 Latin America Vaccines Administered Orally Revenue by Type (2017-2028)
9.2 Latin America Vaccines Administered Orally Market Size by Application
9.2.1 Latin America Vaccines Administered Orally Sales by Application (2017-2028)
9.2.2 Latin America Vaccines Administered Orally Revenue by Application (2017-2028)
9.3 Latin America Vaccines Administered Orally Market Size by Country
9.3.1 Latin America Vaccines Administered Orally Sales by Country (2017-2028)
9.3.2 Latin America Vaccines Administered Orally Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vaccines Administered Orally Market Size by Type
10.1.1 Middle East and Africa Vaccines Administered Orally Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vaccines Administered Orally Revenue by Type (2017-2028)
10.2 Middle East and Africa Vaccines Administered Orally Market Size by Application
10.2.1 Middle East and Africa Vaccines Administered Orally Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vaccines Administered Orally Revenue by Application (2017-2028)
10.3 Middle East and Africa Vaccines Administered Orally Market Size by Country
10.3.1 Middle East and Africa Vaccines Administered Orally Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vaccines Administered Orally Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Merck Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Lanzhou Institute
11.4.1 Lanzhou Institute Corporation Information
11.4.2 Lanzhou Institute Overview
11.4.3 Lanzhou Institute Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Lanzhou Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Lanzhou Institute Recent Developments
11.5 Serum Institute
11.5.1 Serum Institute Corporation Information
11.5.2 Serum Institute Overview
11.5.3 Serum Institute Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Serum Institute Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serum Institute Recent Developments
11.6 Valneva
11.6.1 Valneva Corporation Information
11.6.2 Valneva Overview
11.6.3 Valneva Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Valneva Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Valneva Recent Developments
11.7 Shanghai United Cell
11.7.1 Shanghai United Cell Corporation Information
11.7.2 Shanghai United Cell Overview
11.7.3 Shanghai United Cell Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Shanghai United Cell Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai United Cell Recent Developments
11.8 Bibcol
11.8.1 Bibcol Corporation Information
11.8.2 Bibcol Overview
11.8.3 Bibcol Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bibcol Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bibcol Recent Developments
11.9 PaxVax
11.9.1 PaxVax Corporation Information
11.9.2 PaxVax Overview
11.9.3 PaxVax Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 PaxVax Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 PaxVax Recent Developments
11.10 Vabiotech
11.10.1 Vabiotech Corporation Information
11.10.2 Vabiotech Overview
11.10.3 Vabiotech Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Vabiotech Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vabiotech Recent Developments
11.11 Tiantan Biological
11.11.1 Tiantan Biological Corporation Information
11.11.2 Tiantan Biological Overview
11.11.3 Tiantan Biological Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Tiantan Biological Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Tiantan Biological Recent Developments
11.12 EuBiologics
11.12.1 EuBiologics Corporation Information
11.12.2 EuBiologics Overview
11.12.3 EuBiologics Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 EuBiologics Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 EuBiologics Recent Developments
11.13 Panacea Biotec Ltd
11.13.1 Panacea Biotec Ltd Corporation Information
11.13.2 Panacea Biotec Ltd Overview
11.13.3 Panacea Biotec Ltd Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Panacea Biotec Ltd Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Panacea Biotec Ltd Recent Developments
11.14 Bio-Med
11.14.1 Bio-Med Corporation Information
11.14.2 Bio-Med Overview
11.14.3 Bio-Med Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Bio-Med Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Bio-Med Recent Developments
11.15 Halfkin Bio-Pharmaceuticals
11.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.15.2 Halfkin Bio-Pharmaceuticals Overview
11.15.3 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Halfkin Bio-Pharmaceuticals Vaccines Administered Orally Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vaccines Administered Orally Industry Chain Analysis
12.2 Vaccines Administered Orally Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vaccines Administered Orally Production Mode & Process
12.4 Vaccines Administered Orally Sales and Marketing
12.4.1 Vaccines Administered Orally Sales Channels
12.4.2 Vaccines Administered Orally Distributors
12.5 Vaccines Administered Orally Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vaccines Administered Orally Industry Trends
13.2 Vaccines Administered Orally Market Drivers
13.3 Vaccines Administered Orally Market Challenges
13.4 Vaccines Administered Orally Market Restraints
14 Key Findings in The Global Vaccines Administered Orally Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer